Congress has initiated new efforts to address supply chain security and supply shortages of critical drugs and medical devices in response to the ongoing outbreak of the novel coronavirus (COVID-19) pandemic.

The CARES ACT will soon require medical device companies to notify the Federal Drug Administration of shortages in critical life-sustaining medical devices, bringing them on par with drug companies already subject to these reporting requirements.

Read the full alert from Edward J. Buthusiem, Briannon Irwin, and Kylie Fultineer.